. Author manuscript; available in PMC: 2021 Dec 1.

Published in final edited form as: Transplantation. 2021 Jun 1;105(6):1297–1302. doi: 10.1097/TP.0000000000003361

Table 2:

Complications after initial LDLT stratified by re-LT versus LDLT only.

Variable	Re-LT	LDLT only	P-value
Hepatic artery thrombosis, N (%)	40 (38.1%)	26 (3.2%)	<0.001
Bile leak, N (%)	38 (36.2%)	219 (26.9%)	0.046
Biliary stricture, N (%)	30 (28.6%)	275 (33.8%)	0.29
Rejection, N (%)	10 (9.5%)	88 (10.8%)	0.69
Infection, N (%)	41 (39.0%)	192 (23.6%)	<0.001
Recurrent disease, N (%)	10 (9.5%)	21 (2.6%)	<0.001
HCV	4 (40.0%)	11 (52.4%)	0.70
Non-HCV^*	6 (60.0%)	10 (47.6%)

Non-HCV recurrent disease included acute liver failure, alcoholic liver disease, cryptogenic cirrhosis, PSC, autoimmune hepatitis, HBV, other chronic liver disease, and HCC.